Learn More
Invivogen InvivoGen Anti-CD20 Monoclonal Antibody, Targets Human CD20, Chimeric Construct, 3 x 100 µg

Supplier: Invivogen HCD20MAB103
InvivoGen Anti-CD20 (Rituximab biosimilar) is a human IgG1 monoclonal antibody that targets the human CD20 antigen, facilitating cell destruction through apoptosis, complement activation, and cell-mediated cytotoxicity. Ideal for scientific research, it is produced in CHO cells with thorough functional testing verified by flow cytometry. Its azide-free, lyophilized formulation ensures stability and ease of use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.